NCT06172049

Brief Summary

To evaluate recent trends in CRC incidence, treatment, and survival in the Southwest China.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,838

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
5.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 6, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 15, 2023

Completed
Last Updated

December 15, 2023

Status Verified

December 1, 2023

Enrollment Period

4 years

First QC Date

December 6, 2023

Last Update Submit

December 14, 2023

Conditions

Colorectal Cancer

Outcome Measures

Primary Outcomes (1)

  • Survival

    Overall survival (OS) untile the end of follow up

    From inclusion until date of death from any cause, or untile the 2023-10-31

Study Arms (1)

CRC cases

Other: treatment

Interventions

treatmentOTHER

the actual treatment CRC patients have reveived

CRC cases

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients who were diagnosed with CRC were included

You may qualify if:

  • Clinical diagnosis of colorectal cancer;
  • Received treatment in medical institutions;
  • Regular follow-up after the diagnosis.

You may not qualify if:

  • Patients who lost to follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

West China Hospital

Chengdu, Sichuan, 640001, China

Location

MeSH Terms

Conditions

Colorectal Neoplasms

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Ziqiang Wang

    West China Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

December 6, 2023

First Posted

December 15, 2023

Study Start

January 1, 2014

Primary Completion

December 31, 2017

Study Completion

October 31, 2023

Last Updated

December 15, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations

CN(1)